KYinno Biotechnology

Beijing, China · Founded 2017 · Privately Held (backing)

Developer of oncology drugs intended to accelerate cancer drug discovery and development. KYinno Biotechnology is based in Beijing, China and was founded in 2017. Its last reported valuation was $68.3 million in Oct 2021. It has raised $59 million.

Last reported valuation

$68.3M

Oct 2026

Priced at

—

Total raised

$59.0M

Last round

—

How much has KYinno Biotechnology raised?

$59.0Macross 0 recorded rounds

Free account

More of KYinno Biotechnology with a free account

·Watch KYinno Biotechnology: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

KYinno Biotechnology investors

9 investors are on record for KYinno Biotechnology, including Beijing State-owned Capital Operation and Management, Renai Capital, BioTrack Capital and China Everbright.

For fundraisers

Raising for a company like KYinno Biotechnology?

9 investors have backed KYinno Biotechnology.

See all 9 investors →

Frequently asked about KYinno Biotechnology

How much has KYinno Biotechnology raised?: KYinno Biotechnology has raised $59.0M in total across 0 recorded funding rounds.